Yahoo Web Search

Search results

    • Lampalizumab Keeps Intraocular Pressure Steady

      Medscape· 12 hours ago

      Monthly intravitreous injections of 0.1 mL of lampalizumab over 1 year were associated with a low risk for adverse events associated with intraocular pressure in patients with geographic atrophy.